Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role

Publisher： Karger

E-ISSN： 1423-0194|101|3|211-222

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.101, Iss.3, 2015-02, pp. : 211-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies

By  

Neuroendocrinology, Vol. 89, Iss. 3, 2009-03 ,pp. : 308-314

Karger

Access to resources Recommend Favorite

Somatostatin and Dopamine-Somatostatin Multiple Ligands Directed towards Somatostatin and Dopamine Receptors in Pituitary Adenomas

By  

Neuroendocrinology, Vol. 83, Iss. 3-4, 2006-10 ,pp. : 258-263

Karger

Access to resources Recommend Favorite

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2016-02 ,pp. : 815-825

Karger

Access to resources Recommend Favorite

Preferential Expression of sst2A over sst2B Somatostatin Receptor Splice Variant in Rat Brain and Pituitary

By  

Neuroendocrinology, Vol. 68, Iss. 1, 2008-03 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

Homologous Upregulation of sst2 Somatostatin Receptor Expression in the Rat Arcuate Nucleus in vivo

By  

Neuroendocrinology, Vol. 74, Iss. 1, 2001-07 ,pp. : 33-42

Karger

Access to resources Recommend Favorite